Compare Nusantara Sawit Sejahtera Tbk. (NSSS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nusantara Sawit Sejahtera Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Nusantara Sawit Sejahtera Tbk. trades at Rp800 (market cap 19.64T, 5.37M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Nusantara Sawit Sejahtera Tbk. is far larger — about 188.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| NSSS | SCPI | |
|---|---|---|
Market Cap | 19.64T | 104.4B |
Volume | 5.37M | — |
Lot | 53.75K | — |
Turnover | 4.24B | — |
Average Price | 788.88 | — |
Value | 4.24B | — |
Indicative Equilibrium Price | 800 | — |
Indicative Equilibrium Volume | 537 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nusantara Sawit Sejahtera Tbk.
PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Read more on NSSS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
